Lv1
50 积分 2025-12-31 加入
FaceAge as a biomarker for prognosis and treatment stratification in a large-scale oncology cohort
9小时前
待确认
Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trial
4个月前
已完结
皖公网安备34019202002308
